Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT00006008 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Leukemia

Interventions

DRUG: arsenic trioxide

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]